Navigation Links
Barrett Katz, MD, MBA, Named CEO of Danube Pharmaceuticals
Date:6/18/2008

ration. Dr. Katz served on the executive committee of the Optic Neuritis Treatment Trial, and has been an active participant and principle investigator of many multi-centre clinical trials.

Dr. Katz currently serves as Clinical Professor of Ophthalmology at New York University School of Medicine as well as at the Weill Medical College of Cornell University. Dr. Katz served as a fellow at Harvard University in Boston, the National Institutes of Health, The National Hospital at Queen's Square in London, and the University of California at San Francisco after completing residencies in Neurology at Harvard Medical School and in Ophthalmology at Tufts-New England Medical Center. He received his MD with honors from the Case Western Reserve University School of Medicine and his AB, magna cum laude, from Colgate University. He is the author of several hundred publications, and the recipient of over two dozen major research grants.

About Danube Pharmaceuticals, Inc.

Danube is a biopharmaceutical company dedicated to the research and development of treatments for diseases of the eye. Danube's lead compound DNB-001, is a small molecule for the treatment of glaucoma available in both oral and topical formulation. In preclinical studies DNB-001 has been shown through novel mechanisms of action to both lower intraocular pressure (IOP) and to provide direct neuroprotective benefits to the optic nerve and its retinal ganglion cells, providing a dual approach to glaucoma therapy not provided by any currently marketed product. DNB-001 has been tested in a Phase I clinical trial in Europe and is currently being studied in a Phase II clinical trial in Europe. For more information on Danube please visit http://www.danubepharma.com .

This news release contains forward-looking statements that involve risks and uncertainties that could cause our actual results and experiences to differ materially from antic
'/>"/>

SOURCE Danube Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. New Study Reports That Ablative Therapy With HALO360 Device Effectively Treats Highest-Risk Category of Barretts Esophagus
2. Ten Latin American Scientists Named 2008 Pew Fellows in the Biomedical Sciences
3. Netsmarts Kevin Scalia Named Chair of the Software and Technology Vendors Association
4. GlaxoSmithKline Named A Top Employer for Promoting Healthy Lifestyles
5. Professors Marc Feldmann and Sir Ravinder Maini Named Winners of the 2008 Dr. Paul Janssen Award for Biomedical Research
6. President and CEO of Velcura Therapeutics Inc. Named the 2008 Grant Thornton Leader and Innovator of the Year
7. Black Box Network Services, ABTECH, Verizon Business and Wyle Named Top Siemens Reseller Partners
8. BioNanomatrix Named Best Management Team at the 2008 Ben Franklin Emerging Business Awards
9. Ash Stevens Inc. Named One of Michigan 50 Companies to Watch
10. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the Annual Meeting of the American Association for Cancer Research (AACR); Scientific Advisory Board Chairman Tyler Jacks Named President-elect
11. James W. Backstrom, M.D., Named Chief Medical Officer of Foundation Radiology Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... (PRWEB) May 17, 2013 RURO ... ezColony version 4.1, a versatile refinement to the ... software solution, improves its advanced methodical management for ... with ezColony 4.1. The network-based platform provides user ... effective research. While continuing to emphasize streamlined tasks, ...
(Date:5/16/2013)... ISPE announced today that ... the newly created position of Vice President of ... be responsible for stimulating ISPE’s revenue growth by ... Society’s Member-led and staff-driven business model, initiating integrated ... membership and product marketing. , “Barbara joins ISPE ...
(Date:5/16/2013)... Kitware , a leading ... new Phase II SBIR funding from the U.S. ... an open-source, high performance computing (HPC) simulation and ... researchers to select only the toolkits and applications ... or analysis tasks. , Manufacturers increasingly rely ...
(Date:5/16/2013)... On average, developing a new drug ... dollars. Despite this investment, less than 10% of drugs ... your clinical trial design optimally structured to balance time, ... Dr. Frederic Sax, Global Head of the Center for ... data, information and technology in upfront clinical trial planning ...
Breaking Biology Technology:RURO Introduces ezColony 4.1 – The Versatile Transgenic Animal Colony Management Software 2ISPE Names Barbara A. Myers, CAE, as Vice President of Professional Development 2Kitware Develops a Customizable Simulation Framework to Provide HPC for Small to Mid-Sized Manufacturers 2Optimizing Clinical Trials Outcomes through Computer Assisted Design, New Life Science Webinar Hosted by Xtalks 2
... United Therapeutics Corporation (NASDAQ: UTHR ) (the ... market and other conditions, $210 million aggregate principal amount of ... accordance with Rule 144A under the Securities Act of 1933, ... grant to the initial purchaser of the notes an option ...
... 2011 PAT and QbD remains a field that ... released by Pharma IQ across the PAT and QbD community it ... they were not implementing PAT/QbD was due to a lack of ... once again opens its doors to industry specialists from the PAT ...
... Reportlinker.com announces that a new market research ... Nanobiotechnology: Applications and Global Markets ... The total market for nanobiotechnology products ... growing at a compound annual growth rate ...
Cached Biology Technology:United Therapeutics Announces Proposed Private Offering of $210 Million of Convertible Senior Notes and Authorization of Stock Repurchase Program 2United Therapeutics Announces Proposed Private Offering of $210 Million of Convertible Senior Notes and Authorization of Stock Repurchase Program 3United Therapeutics Announces Proposed Private Offering of $210 Million of Convertible Senior Notes and Authorization of Stock Repurchase Program 4Establishing the Correct QbD Strategies and Tools Early in the Development Process is Key to Ensuring we Have Robust Quality Products Downstream 2Nanobiotechnology: Applications and Global Markets 2Nanobiotechnology: Applications and Global Markets 3Nanobiotechnology: Applications and Global Markets 4Nanobiotechnology: Applications and Global Markets 5Nanobiotechnology: Applications and Global Markets 6Nanobiotechnology: Applications and Global Markets 7Nanobiotechnology: Applications and Global Markets 8Nanobiotechnology: Applications and Global Markets 9Nanobiotechnology: Applications and Global Markets 10Nanobiotechnology: Applications and Global Markets 11Nanobiotechnology: Applications and Global Markets 12Nanobiotechnology: Applications and Global Markets 13
(Date:5/17/2013)... The Federation of American Societies for Experimental Biology ... Institutes of Health (NIH) funding trends highlighting the devastating ... critical research. The FASEB analysis follows a May 15th ... MD, PhD, who testified that the $1.6 billion cut ... is "having a substantial impact on the scientific community." ...
(Date:5/16/2013)... 17, 2013) Illustrating a commitment to the ... Gastroenterological Association (AGA) Research Foundation has announced the ... Fellowship Award recipients. Supported by the National Institute ... this new award helps underrepresented minority students to ... nutrition research. , "By establishing this new award, ...
(Date:5/16/2013)... FASEB MARC (Maximizing Access to Research Careers) ... The Society for Developmental Biology (SDB) 72nd Annual ... These awards are meant to promote the entry ... into the mainstream of the basic science community ... at the SDB 2013 Annual Meeting. , Awards ...
Breaking Biology News(10 mins):Underrepresented minority students receive fellowships in digestive disease and nutrition research 2
... anti-aging technologies may extend human lifespans at an unprecedented ... economic challenges, says biologist Shripad Tuljapurkar of Stanford University. ... have major implications for the global community in the ... of Population Studies, will give a talk Feb. 17 ...
... Mayr's theory of genetic revolution , introduced in 1954, ... detractors. , Mayr believed that genes interacted with one ... to an interaction of natural selection with genetic drift ... change. , Detractors of the theory object to what ...
... range of diseases in several animal species has been found ... was found most often in the blood of individuals with ... exposure. , A study on these findings was published Wednesday ... by scientists from Oregon State University, the Center for Pediatric ...
Cached Biology News:World faces challenge as life expectancies lengthen, scientist says 2World faces challenge as life expectancies lengthen, scientist says 3World faces challenge as life expectancies lengthen, scientist says 4Ernst Mayr's theory illustrated in genetic epidemiology studies 2Ernst Mayr's theory illustrated in genetic epidemiology studies 3Ernst Mayr's theory illustrated in genetic epidemiology studies 4Ocean virus identified in human blood samples 2Ocean virus identified in human blood samples 3Ocean virus identified in human blood samples 4
... Fully adjustable mixing angle, Variable speed, Digital ... a number of different sized tubes, Spillage ... cultures, keeping biological samples in suspension and ... be used in incubators up to 60C ...
... C6 Flow Cytometer System is a full featured, ... including: the C6 Flow Cytometer, CFlow Software, and ... Flow Cytometer System provides all the capabilities of ... of the price. The C6 Flow Cytometer System ...
... Mini-PROTEAN II multiscreen apparatus is used to screen ... gels. The apparatus can screen up to 40 ... the blot into strips. The apparatus includes a ... accommodate one or two 8 x 7 cm ...
Fingerprinting II Informatix cluster analysis is an optional module that adds dendrogram and phylogenetic tree construction, cluster and group significance, and congruence of techniques functions to ...
Biology Products: